Retatrutide
Retatrutide is an investigational triple agonist targeting the GLP-1, GIP, and glucagon receptors. This 20mg vial is our highest-concentration metabolic compound, formulated for extended dose-ranging studies.
Sold for laboratory research use only. Not for human or animal consumption.
- Verified purity
- 99.4%
- Dose per vial
- 20mg
- Molecular weight
- 4731.3 g/mol
- Sequence
- 39-residue synthetic peptide
- CAS number
- 2381089-83-2
- Form
- Lyophilized powder
- Storage
- -20°C, protect from light
Research applications.
Triple-agonist metabolic research at full research strength.
- 01
GLP-1 / GIP / glucagon triple-receptor agonism studies
- 02
Energy expenditure and metabolic-rate research models
- 03
Body-composition and adiposity in vitro investigations
- 04
Comparative dose-response work against single agonists
This product is sold strictly for laboratory research purposes. It is not intended for human or animal consumption and has not been approved by the FDA. You must be 21 or older and a qualified researcher to purchase.
